$-0.24 EPS Expected for pdvWireless (PDVW), THERAPEUTIC SOL INT (TSOI) Shorts Lowered By 72.18%

May 31, 2017 - By Peter Erickson

THERAPEUTIC SOL INT (OTCMKTS:TSOI) had a decrease of 72.18% in short interest. TSOI’s SI was 3,700 shares in May as released by FINRA. Its down 72.18% from 13,300 shares previously. It closed at $0.0082 lastly. It is down 0.00% since May 31, 2016 and is . It has underperformed by 16.70% the S&P500.

Analysts expect pdvWireless Inc (NASDAQ:PDVW) to report $-0.24 EPS on June, 12.They anticipate $0.23 EPS change or 48.94% from last quarter’s $-0.47 EPS. After having $-0.51 EPS previously, pdvWireless Inc’s analysts see -52.94% EPS growth. The stock increased 3.97% or $0.9 during the last trading session, reaching $23.55. About shares traded. pdvWireless Inc (NASDAQ:PDVW) has declined 32.41% since May 31, 2016 and is downtrending. It has underperformed by 49.11% the S&P500.

Therapeutic Solutions International, Inc. is focused on immune modulation for the treatment of several specific diseases. The company has market cap of $6.28 million. TSOI is developing a range of immune-modulatory agents to target certain cancers, improve maternal and fetal health, fight periodontal disease, and for daily health. It currently has negative earnings. The Company’s ProJuvenol is a blend of complex anti-aging ingredients to help promote cellular rejuvenation and healthy functionality for everyday living, based upon pterostilbene.

pdvWireless, Inc., formerly Pacific DataVision, Inc., is a wireless communications carrier and a well-known provider of mobile workforce communication and location solutions. The company has market cap of $335.55 million. The Company’s solutions focus on enhancing the productivity of its customers’ field workers, and the efficiency of their dispatch and call center operations. It currently has negative earnings. The Firm is deploying and operating the two-way radio networks that offer push-to-talk communications services to primarily dispatch-centric, small and medium-sized businesses.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.